Pearson Mark E.

Avg. Two Year Performance

62% Avg. Purchase Return
27% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(5%)(18%)(27%)(16%)62%
Purchase Success Rate0 of 10 of 10 of 10 of 11 of 1
Average Sale Return----------
Sale Success Rate----------

DOR BioPharma, Inc.

Drugs » Biotechnology

Director, 10% Owner:

Holdings: 2.58M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--